Assessment of low-grade hepatic encephalopathy: A critical analysis

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 642-650

  Kircheis, Gerald ^a   Fleig, Wolfgang E ^b   Görtelmeyer, Roman ^c,d   Grafe, Susanne ^c   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c MERZ PHARMACEUTICALS GMBH   (Germany)

^d UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Cirrhosis; Minimal hepatic encephalopathy; Paper pencil tests; Psychometry

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PAPER PENCIL TEST; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY; SCORING SYSTEM; WEST HAVEN CRITERIA;

COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; EVALUATION STUDIES AS TOPIC; FIBROSIS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER DISEASES; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRAIL MAKING TEST;

EID: 34848880485     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.05.019     Document Type: Article

References (44)

1. Parsons-Smith B.G., Summerskill W.H., Dawson A.M., and Sherlock S. The electroencephalograph in liver disease. Lancet 2 (1957) 867-871
2. Conn H.O., Leevy C.M., Vlahcevic Z.R., Rodgers J.B., Maddrey W.C., Seef L., et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 72 (1977) 573-583
3. Conn H.O. Quantifying the severity of hepatic encephalopathy. In: Conn H.O., and Bircher J. (Eds). Hepatic encephalopathy: syndromes and therapies (1993), Medi-Ed Press, East Lansing, Michigan 13-26
4. Rikkers L., Jenko P., Rudman D., and Freides D. Subclinical hepatic encephalopathy: detection, prevalence and relationship to nitrogen metabolism. Gastroenterology 75 (1978) 462-469
5. Schomerus H., Hamster W., Blunck H., Reinhard U., Mayer K., and Dölle W. Latent portosystemic encephalopathy. Nature of cerebral function defects and their effect on fitness to drive. Dig Dis Sci 16 (1981) 321-328
6. Conn H.O. Subclinical hepatic encephalopathy. In: Conn H.O., and Bircher J. (Eds). Hepatic encephalopathy: syndromes and therapies (1993), Medi-Ed Press, East Lansing, Michigan 27-42
7. Quero J.C., and Schalm S.W. Subclinical hepatic encephalopathy. Sem Liv Dis 16 (1996) 321-328
8. Groeneweg M., Quero J.C., De Bruijn I., Hartmann I.J.C., Essink-Bot M.L., Hop W.C.J., et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28 (1998) 45-49
9. Amodio P., Del Piccolo F., Marchetti P., Angeli P., Iemmolo R., Caregaro L., et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29 (1999) 1662-1667
10. Ferenci P, Lockwood AR, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998; Hepatology 2002:35;716-721.
11. Weissenborn K. Minimal hepatic encephalopathy: a permanent source of discussion. Hepatology 35 (2002) 494-495
12. Schomerus H., and Schreiegg J. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 31 (1993) 231-234
13. Yen C.-L., and Liaw Y.-F. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterology 37 (1990) 332-334
14. Weissenborn K., Scholz M., Hinrichs H., Wiltfang L., Schmidt F.W., and Künkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 75 (1990) 289-295
15. Quero J.C., Hartmann I.J., Meulstee J., Hop W.C., and Schalm S.W. The diagnosis of subclinical encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 24 (1996) 556-560
16. Amodio P., Quero J.C., Del Piccolo F., Gatta A., and Schalm S.W. Diagnostic tests for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG. Metab Brain Dis 11 (1996) 315-328
17. Amodio P., Montagnese S., Gatta A., and Morgan M. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19 (2004) 253-267
18. Weissenborn K., Ennen J.C., Schomerus H., Rückert N., and Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34 (2001) 768-773
19. Weissenborn K., Rückert N., Hecker H., and Manns M.P. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 28 (1998) 646-653
20. Zeneroli M.L., Cioni G., Ventura P., Russo A.M., Venturini I., Casalgrandi G., et al. Interindividual variability of the number connection test. J Hepatol 15 (1992) 263-264
21. Conn H.O. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22 (1977) 541-550
22. American Psychological Association (eds). Standards for educational and psychological testing. Washington DC; 1999.
23. Lord F.M., and Novick M.R. Statistical theories of mental test scores (1968), Addison-Wesley, Reading, Massachusetts
24. Kugler C., Lotterer E., Petter J., Wensing G., Taghavy A., Hahn E.G., et al. Visual event related P300 potentials in early portosystemic encephalopathy. Gastroenterology 103 (1992) 302-310
25. Hollerbach S., Kullmann F., Fründ R., Lock G., Geissler A., Schölmerich J., et al. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy - topographic distribution and correlation with clinical and psychometric assessment. Hepatogastroenterology 44 (1997) 1002-1012
26. Saxena N., Bhatia M., Joshi Y.K., Garg P.K., and Tandon R.K. Auditory P300 event-related potentials and number connection test für evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol 16 (2001) 322-327
27. Kircheis G., Wettstein M., Timmermann L., Schnitzler A., and Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35 (2002) 357-366
28. Watanabe A., Tuchida T., Yata Y., and Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 10 (1995) 239-248
29. Ortiz M., Cordoba J., Jacas C., Flavia M., Esteban R., and Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 44 (2006) 104-110
30. Wein C., Koch H., Popp B., Oehler G., and Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39 (2004) 739-745
31. Schomerus H, Weissenborn K, Hamster W, Rückert N, Hecker H. PSE Syndrome test manual. Frankfurt: Swets Test Services; 1999.
32. Hamster W. Neuropsychologie der latenten portosystemischen Enzephalopathie (1982), Habilitationsschrift, Medizinische Fakultät der Eberhard-Karls-Universität Tübingen, Tübingen
33. Schomerus H., and Hamster W. Neuropsychological aspects of portalsystemic encephalopathy. Metab Brain Dis 13 (1998) 361-377
34. Romero-Gómez M., Córdoba J., Jover R., del Olmo J.A., Rami{dotless}́rez M., Rey R., et al. Value of critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45 (2007) 879-885
35. Fleig W.E., Kircheis G., Spengler U., Zeuzem S., Görtelmeyer R., and the German-Austrian-Swiss Multicenter Study Group. Placebo-controlled, double-blind evaluation of l-ornithine-l-aspartate (LOLA) granules in patients with cirrhosis and subclinical (SHE) or mild overt hepatic encephalopathy (HE). J Hepatol 30 (1999) 65 (abstract)
36. World Medical Association (WMA) Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects, adopted by the 18th WMA General Assembly, Helsinki, Finland, 1964, amended by the 29th WMA General Assembly, Tokyo, Japan, 1975 and the 35th WMA General Assembly, Venice, Italy 1983. World Medical Organization. Declaration of Helsinki (1964).
37. Kircheis G., Nilius R., Berndt H., Buchner M., Held C., Hendricks R., et al. Therapeutic efficacy of l-ornithine-l-aspartate infusion concentrate in patients with liver cirrhosis and hepatic encephalopathy: a placebo-controlled double-blind study. Hepatology 25 (1997) 1351-1360
38. Christensen S.E., Elsass P., and Vilstrup H. Number Connection Test and continuous reaction times in non-encephalopathic patients: a comparative study. J Appl Toxicol 1 (1981) 262-263
39. Elsass P., Christensen S.E., Jorgensen F., Mortensen E.L., and Vilstrup H. Number Connection Test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta Pharmacol Toxicol (Copenh) 54 (1984) 115-119
40. Uribe M., Marquez M.A., Garcia Ramos G., Ramos-Uribe M.H., Vargas F., Villalobos A., et al. Treatment of chronic portal-systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 27 (1982) 1109-1116
41. Sushma S., Dasarathy S., Tandon R.K., Jain S., Gupta S., and Bhist M.S. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 16 (1992) 138-144
42. Morgan M.Y., Hawley K.E., and Stambuk D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomized, cross-over study. J Hepatol 4 (1987) 236-244
43. Schomerus H., and Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16 (2001) 37-41
44. Häussinger D., Cordoba J., Kircheis G., Vilstrup H., Fleig W.E., Jones E.A., et al. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D., Kircheis G., and Schliess F. (Eds). Hepatic encephalopathy and nitrogen metabolism (2006), Springer-Verlag, Dordrecht, The Netherlands 423-432